K200117 is an FDA 510(k) clearance for the Trevo NXT ProVue Retriever. This device is classified as a Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (Class II - Special Controls, product code POL).
Submitted by Stryker (Fremont, US). The FDA issued a Cleared decision on February 7, 2020, 17 days after receiving the submission on January 21, 2020.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5600. A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature..
| 510(k) Number | K200117 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | January 21, 2020 |
| Decision Date | February 07, 2020 |
| Days to Decision | 17 days |
| Submission Type | Special |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | POL — Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.5600 |
| Definition | A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature. |